Cleveland Biolabs, Inc. (CBLI) Posts Wider than Expected Q2 Loss
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
NET INCOME/(LOSS) ATTRIBUTABLE TO CLEVELAND BIOLABS, INC.: 1.14M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q2 EPS of ($0.14), $0.10 worse than the analyst estimate of ($0.04).
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Bernstein SocGen on Performance Food Group (PFGC): 'Not the quarter we were hoping for, but LT story intact'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
